Form 8-K - Current report:
SEC Accession No. 0001193125-25-005038
Filing Date
2025-01-13
Accepted
2025-01-13 08:40:45
Documents
40
Period of Report
2025-01-13
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d919433d8k.htm   iXBRL 8-K 35530
2 EX-99.1 d919433dex991.htm EX-99.1 40517
6 GRAPHIC g919433ex99_1p10g1.jpg GRAPHIC 221257
7 GRAPHIC g919433ex99_1p11g1.jpg GRAPHIC 313481
8 GRAPHIC g919433ex99_1p12g1.jpg GRAPHIC 324697
9 GRAPHIC g919433ex99_1p13g1.jpg GRAPHIC 245266
10 GRAPHIC g919433ex99_1p14g1.jpg GRAPHIC 216987
11 GRAPHIC g919433ex99_1p15g1.jpg GRAPHIC 247862
12 GRAPHIC g919433ex99_1p16g1.jpg GRAPHIC 242291
13 GRAPHIC g919433ex99_1p17g1.jpg GRAPHIC 294261
14 GRAPHIC g919433ex99_1p18g1.jpg GRAPHIC 275485
15 GRAPHIC g919433ex99_1p19g1.jpg GRAPHIC 271467
16 GRAPHIC g919433ex99_1p1g1.jpg GRAPHIC 42513
17 GRAPHIC g919433ex99_1p20g1.jpg GRAPHIC 277736
18 GRAPHIC g919433ex99_1p21g1.jpg GRAPHIC 34571
19 GRAPHIC g919433ex99_1p22g1.jpg GRAPHIC 252358
20 GRAPHIC g919433ex99_1p23g1.jpg GRAPHIC 329686
21 GRAPHIC g919433ex99_1p24g1.jpg GRAPHIC 250542
22 GRAPHIC g919433ex99_1p25g1.jpg GRAPHIC 262490
23 GRAPHIC g919433ex99_1p26g1.jpg GRAPHIC 277464
24 GRAPHIC g919433ex99_1p2g1.jpg GRAPHIC 81579
25 GRAPHIC g919433ex99_1p3g1.jpg GRAPHIC 683001
26 GRAPHIC g919433ex99_1p4g1.jpg GRAPHIC 334720
27 GRAPHIC g919433ex99_1p5g1.jpg GRAPHIC 233020
28 GRAPHIC g919433ex99_1p6g1.jpg GRAPHIC 274066
29 GRAPHIC g919433ex99_1p7g1.jpg GRAPHIC 337065
30 GRAPHIC g919433ex99_1p8g1.jpg GRAPHIC 181570
31 GRAPHIC g919433ex99_1p9g1.jpg GRAPHIC 380338
  Complete submission text file 0001193125-25-005038.txt   9700867

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA rprx-20250113.xsd EX-101.SCH 2856
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE rprx-20250113_lab.xml EX-101.LAB 17235
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rprx-20250113_pre.xml EX-101.PRE 10816
43 EXTRACTED XBRL INSTANCE DOCUMENT d919433d8k_htm.xml XML 3556
Mailing Address 110 EAST 59TH STREET NEW YORK NY 10022
Business Address 110 EAST 59TH STREET NEW YORK NY 10022 (212) 883-0200
Royalty Pharma plc (Filer) CIK: 0001802768 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39329 | Film No.: 25525006
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)